Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 949

Innovusion gets $30m funding infusion

The lidar technology startup has secured funding in a series A round co-led by Nio's corporate venturing arm and Fidelity's Eight Roads Ventures and F-Prime Capital units.

Oct 30, 2018

Rakuten to exit as MakeLeaps jumps to Ricoh

Rakuten has scored an exit from digital invoicing platform MakeLeaps after Ricoh agreed to buy the company for a reported eight-figure amount.

Oct 29, 2018

Wukongbao claims series B funding

Guohua Life Insurance and 58 Group supplied series B funding for online insurance platform Wukongbao, adding to $15.3m in pre-series A funding in 2016.

Oct 29, 2018

QinBaoBao enters series C stage

TAL Education joined conglomerate Fosun and VC firm Shunwei Capital in a round for parenting app developer QinBaoBao sized in the eight-digit dollar range.

Oct 29, 2018

News round up 29 October 2018

A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.

Oct 29, 2018

Epic reaches next level with $1.25bn

Axiomatic was among the new investors in Epic Games, developer of the hugely popular Fortnite, which is now valued at almost $15bn.

Oct 29, 2018

Tado fires up $50m round

Amazon, Eon and Čez Group have backed a $50m funding round for smart thermostat manufacturer Tado that nearly doubled its equity to $102m.

Oct 29, 2018

Galecto collects $90m in series C

Bristol Myers-Squibb, Merck Group and Novo all took part in a $90m series C round for Galecto Biotech, which is commercialising research from Lund and Edinburgh universities.

Oct 29, 2018

Sitka absorbs $1.9m

Quark Venture and GF Securities have invested $1.9m in Sitka Biopharma, a spinout of University of British Columbia and Centre for Drug Research and Development.

Oct 29, 2018

Galecto collects $90m in series C

Bristol Myers-Squibb, Merck Group and Novo all took part in a $90m series C round for Galecto Biotech that was co-led by Ysios Capital and OrbiMed.

Oct 29, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here